JP2010520917A5 - - Google Patents

Download PDF

Info

Publication number
JP2010520917A5
JP2010520917A5 JP2009553146A JP2009553146A JP2010520917A5 JP 2010520917 A5 JP2010520917 A5 JP 2010520917A5 JP 2009553146 A JP2009553146 A JP 2009553146A JP 2009553146 A JP2009553146 A JP 2009553146A JP 2010520917 A5 JP2010520917 A5 JP 2010520917A5
Authority
JP
Japan
Prior art keywords
azepino
tetrahydro
indole
sulfonyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009553146A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010520917A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/053002 external-priority patent/WO2008110598A1/en
Publication of JP2010520917A publication Critical patent/JP2010520917A/ja
Publication of JP2010520917A5 publication Critical patent/JP2010520917A5/ja
Withdrawn legal-status Critical Current

Links

JP2009553146A 2007-03-13 2008-03-13 肥満治療用三環式イソキノリン誘導体 Withdrawn JP2010520917A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0700611 2007-03-13
US202907P 2007-11-05 2007-11-05
PCT/EP2008/053002 WO2008110598A1 (en) 2007-03-13 2008-03-13 Tricyclic isoquinoline derivatives for treatment of obesity

Publications (2)

Publication Number Publication Date
JP2010520917A JP2010520917A (ja) 2010-06-17
JP2010520917A5 true JP2010520917A5 (enExample) 2011-05-06

Family

ID=39462457

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009553146A Withdrawn JP2010520917A (ja) 2007-03-13 2008-03-13 肥満治療用三環式イソキノリン誘導体

Country Status (10)

Country Link
US (1) US8138333B2 (enExample)
EP (1) EP2134714A1 (enExample)
JP (1) JP2010520917A (enExample)
CN (1) CN101631787A (enExample)
AU (1) AU2008225753A1 (enExample)
BR (1) BRPI0808791A2 (enExample)
CA (1) CA2679346A1 (enExample)
EA (1) EA016592B1 (enExample)
NZ (1) NZ579360A (enExample)
WO (1) WO2008110598A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2724449C (en) 2008-05-29 2017-05-30 Albany Molecular Research, Inc. 5-ht3 receptor modulators, methods of making, and use thereof
EP2575815A4 (en) 2010-06-04 2013-12-25 Albany Molecular Res Inc GLYCIN TRANSPORTER 1 INHIBITORS, METHODS OF MAKING THE SAME, AND USES THEREOF
WO2012106448A1 (en) * 2011-02-02 2012-08-09 Biocryst Pharmaceuticals, Inc. Heterocyclic compounds as janus kinase inhibitors
JP6198715B2 (ja) * 2012-03-06 2017-09-20 武田薬品工業株式会社 三環性化合物
US10675283B2 (en) 2017-03-24 2020-06-09 University Of South Florida Compositions and methods for white to beige adipogenesis
CN109180687A (zh) * 2018-08-31 2019-01-11 山东轩德医药科技有限公司 一种瑞卡帕步中间体的制备方法
CN111961047A (zh) * 2020-08-19 2020-11-20 南通大学 一种6-乙氧基-3,4-二氢-2,7-萘啶-1(2h)-酮及其合成方法
CN115925658B (zh) * 2022-11-21 2024-02-27 常州佳德医药科技有限公司 一种2-氨基乙基呋喃的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795451A (fr) * 1972-02-23 1973-08-16 Pfizer Agents hypoglycemiants aza indoliques tricycliques
US3950343A (en) * 1973-11-06 1976-04-13 Ayerst, Mckenna And Harrison Ltd. Pyrroloisoquinoline derivatives
MX9700693A (es) 1994-07-26 1997-04-30 Pfizer Derivados del 4-indol.
US6133287A (en) * 1998-03-24 2000-10-17 Allelix Biopharmaceuticals Inc. Piperidine-indole compounds having 5-HT6 affinity
GB9820113D0 (en) 1998-09-15 1998-11-11 Merck Sharp & Dohme Therapeutic agents
MXPA01005905A (es) 1998-12-11 2002-09-18 Univ Virginia Commonwealth Ligandos selectivos de receptores de 5-ht6.
WO2002032863A1 (en) 2000-10-20 2002-04-25 Biovitrum Ab 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
PL374401A1 (en) * 2002-06-05 2005-10-17 F.Hoffmann-La Roche Ag 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders

Similar Documents

Publication Publication Date Title
JP2010520917A5 (enExample)
RU2485114C2 (ru) Карбоксамидные соединения и их применение в качестве ингибиторов кальпаинов
TWI492942B (zh) Cyp17抑制劑
AU2005215918C1 (en) Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors
KR101730681B1 (ko) C형 간염 바이러스 억제제
RU2326881C9 (ru) Конденсированные производные азолпиримидина, обладающие свойствами ингибитора фосфатидилинозитол-3-киназы (pi3k)
RU2223116C2 (ru) Применение производных арил (или гетероарил) азолилкарбинолов в приготовлении лекарственного средства для лечения нарушений, опосредованных избытком вещества p
WO2020210828A1 (en) (aza)indazolyl-aryl sulfonamide and related compounds and their use in treating medical conditions
JP2006521343A5 (enExample)
AU2017265027A1 (en) Heterocyclic modulators of lipid synthesis
CA2602248A1 (en) Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
JP2012528166A5 (enExample)
AU2006284077B2 (en) Use of azabicyclo hexane derivatives
JP2017505762A5 (enExample)
JP2007513915A5 (enExample)
ZA200305619B (en) Substituted triazole diamine derivatives as kinase inhibitors.
TW200922932A (en) Heterocyclic compound and pharmaceutical composition thereof
RU2009146851A (ru) Гетероарил-замещенные пиразольные производные, которые могут использоваться для лечения гиперпролиферативных нарушений и заболеваний, связанных с ангиогенезом
JP2012525431A5 (enExample)
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
JP2012525332A5 (enExample)
KR20020038959A (ko) 티로신 키나제 억제제
IL295076B1 (en) Piperidinone derivatives as MDM2 inhibitors for cancer treatment
JP2006514011A5 (enExample)
JP2012502006A5 (enExample)